Request Demo
Last update 08 Nov 2025
Tocilizumab Biosimilar(CuraTeQ)
Last update 08 Nov 2025
Overview
Basic Info
Drug Type Biosimilar, Monoclonal antibody |
Synonyms Tocilizumab Biosimilar (Curateq Biologics Pvt Ltd.), 托珠单抗生物类似药（Curateq Biologics Pvt Ltd.）, BP 08 + [2] |
Target |
Action antagonists |
Mechanism IL-6RA antagonists(Interleukin-6 receptor alpha subunit antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 12264H
The sequence is quoted from: *****
Sequence Code 12270L
The sequence is quoted from: *****
Related
3
Clinical Trials associated with Tocilizumab Biosimilar(CuraTeQ)CTRI/2024/09/073894
A randomized phase 1, double-blind, single dose, three-arm, parallel group comparativePharmacokinetic, Pharmacodynamic, safety, and immunogenicity assessment of BP08 (Tocilizumab) versus US licensed Actemra® and EU approved RoActemra® administration through the Intravenous infusion route in healthy adult male subjects. - NIL
CTRI/2023/01/049000
A Randomized, Double Blind, Multicenter, Parallel Group Study to Compare Efficacy, Safety, Immunogenicity, Pharmacokinetics and Pharmacodynamics of BP08 (Tocilizumab) and RoActemra® in patients with moderate to severe Rheumatoid Arthritis (RA) with inadequate response to Methotrexate - NA
CTRI/2021/09/036973
A Randomized, Open-Label, Parallel Group Study to Compare Efficacy and Safety of BP08 plus Standard of Care versus Reference Biologic Tocilizumab (Actemra�®/RoActemra�®) plus Standard of Care in Patients with Severe COVID-19 Disease
100 Clinical Results associated with Tocilizumab Biosimilar(CuraTeQ)
Login to view more data
100 Translational Medicine associated with Tocilizumab Biosimilar(CuraTeQ)
Login to view more data
100 Patents (Medical) associated with Tocilizumab Biosimilar(CuraTeQ)
Login to view more data
100 Deals associated with Tocilizumab Biosimilar(CuraTeQ)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rheumatoid Arthritis | Phase 3 | India | 01 Feb 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free